Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors.
The serine/threonine kinase LKB1 is a tumour suppressor that regulates multiple biological pathways, including cell cycle control, cell polarity and energy metabolism by direct phosphorylation of 14 different AMP-activated protein kinase (AMPK) family members. Although many downstream targets have b...
Main Authors: | Nicolas Lützner, Johanna De-Castro Arce, Frank Rösl |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3295762?pdf=render |
Similar Items
-
ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.
by: Elton Zeqiraj, et al.
Published: (2009-06-01) -
56371 The Signaling Axis of Tumor Suppressor LKB1 in Triple Negative Breast Cancer
by: Khoa Nguyen, et al.
Published: (2021-03-01) -
Oral rapamycin reduces tumour burden and vascularization in Lkb1(+/-) mice.
by: Robinson, J, et al.
Published: (2009) -
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
by: Shuang Qu, et al.
Published: (2022-09-01) -
HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses
by: Simon Langer, et al.
Published: (2019-02-01)